Academic
Publications
Fas and Fas ligand: lpr and gld mutations

Fas and Fas ligand: lpr and gld mutations,10.1016/0167-5699(95)80069-7,Immunology Today,Shigekazu Nagata,Takashi Suda

Fas and Fas ligand: lpr and gld mutations   (Citations: 400)
BibTex | RIS | RefWorks Download
Fas ligand (FasL) is a death factor that binds to its receptor, Fas, and induces apoptosis. Two mutations that accelerate autoimmune disease, lpr and gld, are known to correspond to mutations within genes encoding Fas and FasL, respectively. Here, Shigekazu Nagata and Takashi Suda summarize current knowledge of Fas and FasL, and discuss the physiological role of the Fas system in T-cell development, cytotoxicity and cytotoxic T lymphocyte (CTL)-mediated autoimmune disease.
Journal: Immunology Today - IMMUNOL TODAY , vol. 16, no. 1, pp. 39-43, 1995
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
Sort by: